Doug Schenkel
Stock Analyst at Wolfe Research
(2.84)
# 1,539
Out of 5,182 analysts
61
Total ratings
50%
Success rate
32.52%
Average return
Main Sectors:
Stocks Rated by Doug Schenkel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BRKR Bruker | Upgrades: Outperform | $60 | $36.53 | +64.25% | 3 | Dec 10, 2025 | |
| WAT Waters | Upgrades: Outperform | $480 | $299.79 | +60.11% | 2 | Dec 10, 2025 | |
| GH Guardant Health | Upgrades: Outperform | $75 | $88.50 | -15.25% | 3 | Sep 25, 2025 | |
| CAI Caris Life Sciences | Initiates: Outperform | $32 | $19.93 | +60.56% | 1 | Jul 14, 2025 | |
| TEM Tempus AI | Initiates: Outperform | $60 | $52.68 | +13.90% | 1 | Dec 13, 2024 | |
| TWST Twist Bioscience | Initiates: Outperform | $60 | $61.00 | -1.64% | 2 | Dec 13, 2024 | |
| STVN Stevanato Group | Initiates: Outperform | $28 | $16.18 | +73.05% | 1 | Dec 13, 2024 | |
| WST West Pharmaceutical Services | Initiates: Peer Perform | n/a | $302.20 | - | 1 | Dec 13, 2024 | |
| RGEN Repligen | Initiates: Peer Perform | n/a | $118.29 | - | 1 | Nov 14, 2024 | |
| MRVI Maravai LifeSciences Holdings | Initiates: Peer Perform | n/a | $3.68 | - | 1 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $285 | $180.62 | +57.79% | 2 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $115.62 | - | 8 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $49 | $38.09 | +28.77% | 2 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $22.28 | - | 3 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $128.52 | - | 5 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $468.04 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $4.83 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $86.80 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $1.59 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $7.97 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $204.39 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $4.86 | - | 1 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $4.85 | - | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $2.00 | - | 1 | Aug 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $6.74 | - | 1 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.95 | - | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $19.06 | - | 1 | Jul 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $18 | $2.65 | +579.25% | 1 | Jun 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $19.82 | - | 2 | Mar 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $90 | $188.31 | -52.21% | 2 | Feb 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $3.21 | - | 1 | Jan 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $138.11 | - | 1 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $16 | $61.41 | -73.95% | 2 | Sep 28, 2017 |
Bruker
Dec 10, 2025
Upgrades: Outperform
Price Target: $60
Current: $36.53
Upside: +64.25%
Waters
Dec 10, 2025
Upgrades: Outperform
Price Target: $480
Current: $299.79
Upside: +60.11%
Guardant Health
Sep 25, 2025
Upgrades: Outperform
Price Target: $75
Current: $88.50
Upside: -15.25%
Caris Life Sciences
Jul 14, 2025
Initiates: Outperform
Price Target: $32
Current: $19.93
Upside: +60.56%
Tempus AI
Dec 13, 2024
Initiates: Outperform
Price Target: $60
Current: $52.68
Upside: +13.90%
Twist Bioscience
Dec 13, 2024
Initiates: Outperform
Price Target: $60
Current: $61.00
Upside: -1.64%
Stevanato Group
Dec 13, 2024
Initiates: Outperform
Price Target: $28
Current: $16.18
Upside: +73.05%
West Pharmaceutical Services
Dec 13, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $302.20
Upside: -
Repligen
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $118.29
Upside: -
Maravai LifeSciences Holdings
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $3.68
Upside: -
Oct 31, 2024
Upgrades: Outperform
Price Target: $285
Current: $180.62
Upside: +57.79%
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $115.62
Upside: -
Jun 27, 2024
Upgrades: Outperform
Price Target: $49
Current: $38.09
Upside: +28.77%
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $22.28
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $128.52
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $468.04
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $4.83
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $86.80
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $1.59
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $7.97
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $204.39
Upside: -
Aug 17, 2021
Initiates: Outperform
Price Target: n/a
Current: $4.86
Upside: -
Aug 16, 2021
Initiates: Market Perform
Price Target: n/a
Current: $4.85
Upside: -
Aug 9, 2021
Initiates: Outperform
Price Target: n/a
Current: $2.00
Upside: -
Jan 12, 2021
Initiates: Outperform
Price Target: n/a
Current: $6.74
Upside: -
Dec 29, 2020
Initiates: Outperform
Price Target: n/a
Current: $1.95
Upside: -
Jul 7, 2020
Initiates: Outperform
Price Target: n/a
Current: $19.06
Upside: -
Jun 19, 2018
Initiates: Outperform
Price Target: $18
Current: $2.65
Upside: +579.25%
Mar 28, 2018
Upgrades: Outperform
Price Target: n/a
Current: $19.82
Upside: -
Feb 22, 2018
Maintains: Outperform
Price Target: $80 → $90
Current: $188.31
Upside: -52.21%
Jan 2, 2018
Initiates: Outperform
Price Target: n/a
Current: $3.21
Upside: -
Nov 1, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $138.11
Upside: -
Sep 28, 2017
Maintains: Outperform
Price Target: $23 → $16
Current: $61.41
Upside: -73.95%